ResMed
HIMSS21
ResMed is enabling interoperability inside and outside the hospital, says Nick Knowlton, VP of Strategic Initiatives.
ResMed is partnering with Providence St. Joseph to give clinicians insights into helping patients be more compliant, says ResMed's VP of SaaS Strategy Annie McBride.
ResMed is expected to close the $225M deal to purchase the smart inhaler company by March 2019.